Compositions and methods for treating late-onset Pompe disease
US-12533396-B2 · Jan 27, 2026 · US
This page is not indexed by search engines while we improve data quality.
Finn Patrick patents
Finn Patrick is listed as an inventor on 29 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Finn Patrick |
| Total patents | 29 |
| First publication | Jun 25, 2015 |
| Latest publication | Jan 27, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Compositions and methods for treating pompe disease
US-2025319166-A1 · Oct 16, 2025 · US
Polynucleotides encoding glucose-6-phosphatase for the treatment of glycogen storage disease type 1a (gsd1a)
US-2025090684-A1 · Mar 20, 2025 · US
Compositions and methods for treating Pompe disease
US-12251430-B2 · Mar 18, 2025 · US
Oligosaccharide-protein conjugates
US-12252504-B2 · Mar 18, 2025 · US
Anti-tgf-beta antibodies and their use
US-2025026821-A1 · Jan 23, 2025 · US
Anti-TGF-beta antibodies and their use
US-12049496-B2 · Jul 30, 2024 · US
Polynucleotides encoding ornithine transcarbamylase for the treatment of urea cycle disorders
US-2024247239-A1 · Jul 25, 2024 · US
Polynucleotides encoding phenylalanine hydroxylase for the treatment of phenylketonuria
US-11939601-B2 · Mar 26, 2024 · US
Polynucleotides encoding ornithine transcarbamylase for the treatment of urea cycle disorders
US-11859215-B2 · Jan 2, 2024 · US
Recent patents
Latest publications not already listed above.
Compositions and methods for treating late-onset pompe disease
US-2023256062-A1 · Aug 17, 2023 · US
Phenylalanine hydroxylase variants and uses thereof
US-2023235298-A1 · Jul 27, 2023 · US
Oligosaccharide-protein conjugates
US-2022242899-A1 · Aug 4, 2022 · US
Anti-tgf-beta antibodies and their use
US-2022195026-A1 · Jun 23, 2022 · US
Oligosaccharide-protein conjugates
US-11279725-B2 · Mar 22, 2022 · US
Anti-TGF-beta antibodies and their use
US-11242384-B2 · Feb 8, 2022 · US
Compositions and methods for treating pompe disease
US-2021244803-A1 · Aug 12, 2021 · US
Polynucleotides encoding phenylalanine hydroxylase for the treatment of phenylketonuria
US-2021040456-A1 · Feb 11, 2021 · US
Anti-tgf-beta antibodies and their use
US-2020399358-A1 · Dec 24, 2020 · US
Polynucleotides encoding ornithine transcarbamylase for the treatment of urea cycle disorders
US-2020299652-A1 · Sep 24, 2020 · US
Anti-TGF-β antibodies and their use
US-10766955-B2 · Sep 8, 2020 · US
Oligosaccharide-protein conjugates
US-2020216485-A1 · Jul 9, 2020 · US
Oligosaccharide-protein conjugates
US-10464962-B2 · Nov 5, 2019 · US
Method of treating primary focal segmental glomerulosclerosis
US-2019062416-A1 · Feb 28, 2019 · US
Anti-tgf-beta antibodies and their use
US-2018244763-A1 · Aug 30, 2018 · US
Oligosaccharide-protein conjugates
US-2018002365-A1 · Jan 4, 2018 · US
Oligosaccharide-protein conjugates
US-9493498-B2 · Nov 15, 2016 · US
Method and system for scheduling a meeting
US-2016063449-A1 · Mar 3, 2016 · US
Oligosaccharide-protein conjugates
US-2015175643-A1 · Jun 25, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Genzyme Corp | 14 |
| Sanofi Sa | 7 |
| Modernatx Inc | 7 |
| Moderna Tx Inc | 1 |
| Fmr Llc | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P3/00 | 14 |
| A61P43/00 | 13 |
| A61K47/61 | 11 |
| A61K9/0019 | 10 |
| C07H15/04 | 8 |